← ANALYST RATINGS · TIPRANKS
Whitehawk Therapeutics (WHWK): analyst forecast and price target
Analyst consensus
Moderate Buy1 Buy1 Hold0 Sell
Ratings of 2 analysts in the last 3 months · top analysts only12-month forecast
Based on 2 price targets given in the last 3 months, the average target is $7.00, the highest $7.00, the lowest $7.00. The average is +142.2% from the last price of $2.89.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $3.50 → $3.00−14.3% | Hold | +3.8% | Reiterated | 14.10.26on TipRanks 07:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $3.50 → $3.00−14.3% | Hold | +3.8% | Reiterated | 14.10.26on TipRanks 07:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $3.50 → $3.00−14.3% | Hold | +3.8% | Reiterated | 14.10.26on TipRanks 07:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $3.50 → $3.00−14.3% | Hold | +3.8% | Reiterated | 14.10.26on TipRanks 07:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $3.50 → $3.00−14.3% | Hold | +3.8% | Reiterated | 14.10.26on TipRanks 07:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $3.50 → $3.00−14.3% | Hold | +3.8% | Reiterated | 14.10.26on TipRanks 07:05 | — | |
| Dara Azar★★★★★★★★★★#9877 · hits 33% · avg −5.2% | Stifel Nicolaus | $9.00 | Buy | +211.4% | Initiated | 30.09.26on TipRanks 16:20 | −0.2%next day −2.3% · 5 days −9.0% | ↗ |
| Boris Peaker★★★★★★★★★★#357 · hits 49% · avg +22.6% | JonesTrading | $7.00 | Buy | +142.2% | Reiterated | 14.09.26on TipRanks 09:15 | −0.5%next day +1.0% · 5 days −2.6% | ↗ |
| Unknown Analyst | Oppenheimer | $7.00 | Buy | +142.2% | Reiterated | 07.08.26on TipRanks Aug 8 00:06 | +0.7%next day −4.4% · 5 days −6.7% | ↗ |
| Tara Bancroft★★★★★★★★★★#361 · hits 55% · avg +30.3% | TD Cowen | — | Hold | — | Reiterated | 06.08.26on TipRanks Aug 7 03:55 | +15.6%next day +0.7% · 5 days −1.6% | ↗ |
| Jonathan Chang★★★★★★★★★★#2398 · hits 37% · avg +7.3% | Leerink Partners | $9.00 | Buy | +211.4% | Initiated | 13.07.26on TipRanks 07:51 | −2.5%next day −1.1% · 5 days −0.4% | ↗ |
| Yuan Zhi★★★★★★★★★★#1180 · hits 41% · avg +20.7% | B. Riley Securities | $10.00 | Buy | +246.0% | Initiated | 25.06.26on TipRanks 08:50 | −6.5%next day +1.9% · 5 days +0.5% | ↗ |
| Robert Burns★★★★★★★★★★#272 · hits 52% · avg +25.9% | H.C. Wainwright | — | Hold | — | Reiterated | 21.04.26on TipRanks 06:25 | −0.1%next day −0.3% · 5 days −2.7% | ↗ |
| Reni Benjamin★★★★★★★★★★#12340 · hits 34% · avg −9.2% | Citizens JMP | $8.00 | Buy | +176.8% | Initiated | 16.04.26on TipRanks 05:30 | +8.2%next day −4.0% · 5 days −2.4% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Whitehawk Therapeutics
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $8.00 at a price of $3.76 (+112.8%); now: $7.67 at $2.89 (+165.3%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 2 | 2 | 1 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 4 | 2 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 11.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.22 (from $-0.27 to $-0.18). Last quarter: $-0.20.
Sales
Next quarter’s sales estimate — $0M (from $0M to $0M). Last quarter: $0M.
Best top-analyst consensus in the sector · Healthcare
About Whitehawk Therapeutics
- CEO: David J. Lennon
- Employees: 32
- 2 Headquarters Plaza, Morristown, NJ, 07960, US
- ir.whitehawktx.com
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Data from the stock’s TipRanks forecast page, read 65 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗